Medicare hits $200 billion in gross drug spend: Who gets the blame?
Ben LinkMedicare, Part D, Brand drugs, Generic drugs, Specialty, DIR fees, Rebates, PBM, Eliquis, Revlimid, Xarelto, Januvia, Trulicity, Imbruvica, Lantus, Jardiance, Humira, Ibrance, NADAC, atorvastatin, WAC
International reference pricing: Discounts Down Under far surpass U.S. drug price concessions
Ben LinkAustralia, International pricing, PBM, NADAC, Eliquis, Rebates, Advair, Fluticasone, Gleevec, Imatinib, Part D, Part B, Aetna, Albuterol
